# Ellume·Lab Flu A+B Test and the Ellume Home Flu Test Performance Versus Viral Culture and Reverse Transcriptase Polymerase Chain Reaction

> **NCT03595358** · NA · COMPLETED · sponsor: **Ellume Pty Ltd** · enrollment: 25 (actual)

## Conditions studied

- Influenza

## Interventions

- **DIAGNOSTIC_TEST:** Ellume Home Flu Test
- **DIAGNOSTIC_TEST:** ellume.lab Flu A+B Test
- **DIAGNOSTIC_TEST:** Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
- **DIAGNOSTIC_TEST:** Viral culture

## Key facts

- **NCT ID:** NCT03595358
- **Lead sponsor:** Ellume Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-31
- **Primary completion:** 2018-11-16
- **Final completion:** 2018-11-16
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2023-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03595358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03595358, "Ellume·Lab Flu A+B Test and the Ellume Home Flu Test Performance Versus Viral Culture and Reverse Transcriptase Polymerase Chain Reaction". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03595358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*